Salubris (Chengdu) Biotech Co., Ltd.

Calculating rank

USPTO Granted Patents = 2

EPO Patents = 1

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Shengwei Li (2 out of 2 patents)

Yiran Wu (2 out of 2 patents)

Dixiang Luo (2 out of 2 patents)

4. Ming Zhou (2 out of 2 patents)

5. Xiaolei Zhuang (2 out of 2 patents)

6. Pengyi Luo (2 out of 2 patents)

7. Liang Hua (2 out of 2 patents)

8. John H Li (2 out of 23 patents)

9. Yang Wang (2 out of 14 patents)

2 patents: Sort by Forward Citations

1. 11718652 - Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof (2023-08-08),

2. 11046741 - Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof (2021-06-29),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#97 in Chengdu

#11,649 in China

Chengdu, China

Salubris (Chengdu) Biotech Co., Ltd.

Forward Citations = 1

9 inventors:

Shengwei Li (2 out of 2 patents)

Yiran Wu (2 out of 2 patents)

Dixiang Luo (2 out of 2 patents)

4. Ming Zhou (2 out of 2 patents)

5. Xiaolei Zhuang (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Salubris (Chengdu) Biotech Co., Ltd.. Retrieved from https://idiyas.com/company/salubris-chengdu-biotech-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]